HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Timothy J Price Selected Research
Timothy J Price Research Topics
Disease
55
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2004
38
Neoplasms (Cancer)
06/2022 - 09/2007
10
Neoplasm Metastasis (Metastasis)
12/2021 - 03/2008
7
Breast Neoplasms (Breast Cancer)
06/2021 - 12/2014
4
Stomach Neoplasms (Stomach Cancer)
12/2021 - 04/2012
3
Wounds and Injuries (Trauma)
04/2019 - 02/2016
3
Sarcoma (Soft Tissue Sarcoma)
11/2017 - 01/2014
3
Infections
05/2017 - 02/2004
3
Exanthema (Rash)
07/2014 - 07/2013
2
Disease Progression
01/2022 - 01/2019
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2018
2
Carcinoma (Carcinomatosis)
01/2021 - 01/2018
2
Colonic Neoplasms (Colon Cancer)
07/2018 - 02/2016
2
Liver Diseases (Liver Disease)
01/2018 - 09/2007
2
Rectal Neoplasms (Rectal Cancer)
05/2017 - 01/2016
2
Hyperammonemia
09/2010 - 09/2007
1
Fibrosis (Cirrhosis)
06/2022
1
Carcinoid Heart Disease
06/2022
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Adenocarcinoma
01/2021
1
Lung Neoplasms (Lung Cancer)
01/2021
1
Triple Negative Breast Neoplasms
08/2019
1
Myocardial Infarction
01/2019
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1
Shock
01/2019
1
Takotsubo Cardiomyopathy
01/2019
1
Gallbladder Neoplasms (Gallbladder Cancer)
08/2018
1
Carcinoid Tumor (Carcinoid)
05/2018
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2018
Drug/Important Bio-Agent (IBA)
16
Cetuximab (Erbitux)
FDA Link
12/2020 - 10/2008
12
Panitumumab (Vectibix)
FDA Link
12/2020 - 07/2013
12
Monoclonal Antibodies
IBA
12/2020 - 10/2008
10
Bevacizumab (Avastin)
FDA Link
01/2022 - 07/2010
10
Biomarkers (Surrogate Marker)
IBA
01/2022 - 12/2011
9
Proteins (Proteins, Gene)
FDA Link
01/2022 - 12/2011
8
ErbB Receptors (EGF Receptor)
IBA
12/2020 - 10/2008
7
Capecitabine (Xeloda)
FDA Link
01/2022 - 07/2010
7
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2022 - 02/2004
6
Biological Products
IBA
01/2017 - 01/2010
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 06/2013
5
Irinotecan (Camptosar)
FDA Link
Generic
12/2018 - 02/2013
5
Fluorouracil (Carac)
FDA Link
Generic
05/2017 - 02/2004
4
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 02/2014
4
Antibodies
IBA
01/2021 - 07/2011
3
Hormones (Hormone)
IBA
06/2022 - 06/2021
3
sotorasib
IBA
01/2022 - 01/2020
3
Estrogens (Estrogen)
FDA Link
06/2021 - 01/2016
3
Progesterone
FDA Link
Generic
06/2021 - 01/2016
3
Estrogen Receptors
IBA
06/2021 - 09/2019
3
Growth Factor Receptors
IBA
07/2013 - 07/2011
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2021 - 02/2013
2
Formaldehyde (Formol)
FDA Link
01/2020 - 08/2014
2
Paraffin
IBA
01/2020 - 08/2014
2
Annexin A5
IBA
04/2019 - 02/2018
2
Propidium (Propidium Iodide)
IBA
04/2019 - 02/2018
2
bacopaside II
IBA
07/2018 - 02/2018
2
Protein Isoforms (Isoforms)
IBA
01/2017 - 01/2012
2
Tensins
IBA
02/2014 - 06/2013
2
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
02/2014 - 06/2013
2
Ammonia
IBA
09/2010 - 09/2007
2
Yttrium
IBA
08/2008 - 03/2008
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
06/2022
1
Aerosols
IBA
12/2021
1
Messenger RNA (mRNA)
IBA
06/2021
1
Progesterone Receptors (Progesterone Receptor)
IBA
06/2021
1
Triterpenes
IBA
05/2021
1
Saponins
IBA
05/2021
1
Chromatin
IBA
01/2021
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2021
1
Cadherins (E-Cadherin)
IBA
01/2021
1
Circulating Tumor DNA
IBA
01/2021
1
Coloring Agents (Dyes)
IBA
01/2021
1
trebananib
IBA
01/2021
1
Keratins (Keratin)
IBA
01/2021
1
Mucins
IBA
01/2021
1
Catenins
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2020
1
Cysteine (L-Cysteine)
FDA Link
11/2019
1
human ERBB2 protein
IBA
09/2019
1
ginsenoside Rg3
IBA
08/2019
1
MicroRNAs (MicroRNA)
IBA
05/2019
1
3- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazolium
IBA
04/2019
1
omega-Chloroacetophenone (Mace)
IBA
01/2019
1
Nexus
IBA
01/2019
1
Catecholamines
IBA
01/2019
1
pro-brain natriuretic peptide (1-76)
IBA
01/2019
1
Normetanephrine
IBA
01/2019
1
C-Reactive Protein
IBA
01/2019
1
IgG Receptors (Fc gamma RI)
IBA
11/2018
1
Peptide Receptors (Peptide Receptor)
IBA
05/2018
1
Radioisotopes (Radionuclides)
IBA
05/2018
1
Everolimus
FDA Link
01/2018
1
atezolizumab
IBA
01/2018
Therapy/Procedure
34
Drug Therapy (Chemotherapy)
01/2022 - 09/2007
33
Therapeutics
12/2020 - 09/2007
5
Radiotherapy
11/2017 - 03/2008
2
Adjuvant Chemotherapy
06/2021 - 01/2020
2
Microspheres (Microsphere)
08/2008 - 03/2008
1
Pancreaticoduodenectomy
08/2018